e-learning
resources
Amsterdam 2015
Sunday, 27.09.2015
Pulmonary hypertension: rare and hereditary causes of PAH
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Functional characterization of BMPR2 gene in pulmonary arterial hypertension
Guillermo Pousada (Vigo, Spain), Guillermo Pousada, Vincenzo Lupo, María álvarez-Satta, Adolfo Baloira, Carmen Espinós, Diana Valverde
Source:
International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH
Session:
Pulmonary hypertension: rare and hereditary causes of PAH
Session type:
Poster Discussion
Number:
593
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Guillermo Pousada (Vigo, Spain), Guillermo Pousada, Vincenzo Lupo, María álvarez-Satta, Adolfo Baloira, Carmen Espinós, Diana Valverde. Functional characterization of BMPR2 gene in pulmonary arterial hypertension. Eur Respir J 2015; 46: Suppl. 59, 593
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The definition of pulmonary hypertension: history, practical implications and current controversies
Should we screen for hereditary pulmonary hypertension?
Patient with ankylosing spondylitis and pulmonary hypertension
Related content which might interest you:
Functional analysis of the 5´UTR region of BMPR2 gene in pulmonary arterial hypertension
Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH
Year: 2015
Molecular characterization of the ACVRL1 and ENG genes in patients with pulmonary arterial hypertension
Source: International Congress 2015 – Promising novel findings in translational pulmonary research
Year: 2015
Analysis of the subcellular localization in BMPR2 gene in pulmonary arterial hypertension
Source: International Congress 2016 – The nature of pulmonary hypertension
Year: 2016
Analysis of BMPR2 gene expression in B-lymphocytes of pulmonary arterial hypertension patients
Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside
Year: 2016
Pulmonary arterial hypertension associated with several mutations
Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside
Year: 2016
Clinical manifestation of hereditary pulmonary arterial hypertension by a ²second hit² mutation in the genes BMPR2 and EIF2AK4
Source: International Congress 2016 – Pulmonary hypertension: the clinic I
Year: 2016
A new molecular genetic diagnostic approach for pulmonary arterial hypertension
Source: International Congress 2016 – The nature of pulmonary hypertension
Year: 2016
Molecular analysis of genes BMPR2 and KCNA5 in Spanish patients with pulmonary arterial hypertension
Source: Annual Congress 2012 - Pulmonary circulation: clinical diagnosis, treatment, end-points and animal models
Year: 2012
Mutational and epigenetic analysis of the promoter region of
BMPR2
gene in patients with pulmonary arterial hypertension
Source: International Congress 2014 – Pulmonary hypertension: pathobiology
Year: 2014
Analysis of miRNA profile in circulating microparticles of patients with pulmonary arterial hypertension
Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH
Year: 2015
Molecular genetics and clinical features of Chinese idiopathic and heritable pulmonary arterial hypertension patients
Source: Eur Respir J 2012; 39: 597-603
Year: 2012
Time-resolved study of endothelial shear-responsiveness in pulmonary arterial hypertension
Source: International Congress 2015 – Pulmonary hypertension: promising small molecules
Year: 2015
PSGR olfactory receptor: A new potential target in pulmonary arterial hypertension
Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside
Year: 2016
Expression of fetal genes in pulmonary arterial hypertension
Source: Annual Congress 2005 - Pulmonary hypertension and fibrosis: novel mechanisms
Year: 2005
Inflammatory mediators contribute to pulmonary arterial cell dysfunction in a pulmonary arterial hypertension patient with
BMPR2
mutation
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Year: 2013
Analysis of pulmonary endothelial microparticles, haemodynamics and functional class in pulmonary hypertension
Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease
Year: 2015
Screening of pulmonary arterial hypertension in BMPR2 mutation carriers
Source: Virtual Congress 2020 – Genetics and genomics of pulmonary arterial hypertension
Year: 2020
Pre-implantation genetic diagnosis in pulmonary arterial hypertension due to BMPR2 mutation
Source: Eur Respir J 2012; 39: 1534-1535
Year: 2012
Pulmonary arterial lesions and interstitial remodeling patterns in histology differentiate EIF2AK4 mutation-carriers from non-carriers with pulmonary veno-occlusive disease
Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH
Year: 2015
Therapeutic potential of DMHCA for pulmonary arterial hypertension (PAH)
Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept